Analysing and processing millions of medical publications, XUND raises €6 million

Vienna’s XUND has raised €6 million in what the startup claims as one of the largest seed rounds in the country to date. Using AI, the company analyses and processes millions of medical publications and offers a medically approved API to formulate a baseline for solutions. The new capital is slated to be used to expand operations outside the DACH region, including both new European markets and a U.S. market entry.

XUND, presumably a play on the word gesund, meaning healthy auf deutsch, combines symptoms, personal risk factors, and demographic data of customers, patients, and employees to help them understand their symptoms, receive reliable assessments on what could be causing them, and take the right next steps.

“Our ambition is to eventually cover the entire patient lifecycle from prevention over diagnosis to treatment and monitoring, allowing XUND to become the central infrastructure provider for digital patient interactions across insurance, pharma, digital and in-person healthcare,” explained XUND CEO and co-founder Tamás Petrovics.

XUND’s €6 million seed round was co-led by MMC Ventures and MassMutual Ventures, with RoX Health (Roche), and LANA Ventures participating.

“With the rise of digitalised workflows in every aspect of healthcare, there is a huge opportunity for XUND’s certified API, enabling stakeholders of the healthcare ecosystem to build their own native symptom assessment and patient navigation solutions, without the regulatory burden of having to become medical device manufacturers themselves,” concluded MMC Ventures’ Charlotte Barttelot.